Result: In our study regarding urine screening tests 42% of our cases had presented positive results in at least one of the urine screening tests. This denotes the importance of urine screening tests for early detection of metabolic diseases among cases of refractory epilepsy. Conclusion :Compared with the positive rate of the urine metabolic screening tests in high risk infants suggest probability of the presence of a metabolic disease, which will need further investigations
INTRODUCTION
pilepsy is a common children's neural disease (1) . Refractory epilepsy May be defined as failure of complete or acceptable control of seizures in response to the antiepileptic drugs. For routine use, failure of seizure-control despite trial of three appropriate anti-epileptic drugs (AED) regimens at maximum tolerated doses should be considered as drug-refractoriness and is highly likely to indicate failure with subsequent AED trials. Another important concern is 'pseudo' or 'apparent' refractoriness. It should be excluded before a diagnosis of refractory epilepsy (2). The factors to be considered includes appropriateness of the drug for the epilepsy syndrome, compliance, 'seizure mimickers', adequate dosing and trial and drug interactions .The pathogenesis of refractory epilepsy is complicated, and remains to be clarified. The development of molecular genetics and biochemistry have led to the finding that refractory epilepsy is closely associated with inherited metabolism(3) (4 -40-disorder (5).Inherited metabolic disorders are a series of metabolic defects of different clinical manifestation, including organic acids, amino acids, fatty acids metabolic disease, which are incurred by disorder of biochemical metabolism and the accumulation of toxic products and the accumulation or insufficiency of metabolites resulting from the structural defects or functional disorders of protein arising from gene mutation (6)(7). The symptoms depend on the particular metabolic pathway that is affected (8).Clinical features of metabolic disorders are non-specific and none of these features alone may point towards a metabolic disorder, so the recent advances in the diagnosis and treatment of inherited metabolic disorders have improved the diagnoses for many of these conditions (9). Method :This study includes 48 patients with refractory epilepsy, cross section study . Urine metabolic screening for all subjects: 25 ml of random sample of urine was collected from each patient in a sterile plastic container containing 0. These results are in agreement with Greenberg,2002(16).. In this study 9 out of 48 patients (19%) who were included in the study presented with jaundice in association with refractory epilepsy of theses cases 2 of cases had positive Benedict's test and 1of cases had positive ferric chloride.
Inborn errors may present with any of the characteristic features of liver disease. Conjugated or unconjugated hyperbilirubinemia can be caused by IEM. Patients with classical galactosemia usually present with vomiting, lethargy, hyperbilirubinemia, and liver failure in the first weeks of life. Reye-like acute encephalopathy with hepatocellular dysfunction is highly suggestive of fatty acid oxidation defects.
Conjugated hyperbilirubinemia associated with some dysmorphic features and hearing loss can be caused by a defect in peroxisomal biogenesis. Neonatal cholestasis can also be caused by bile acid synthesis or transport defects, congenital glycosylation defects, tyrosinemia type 1, or lysosomal storage disorders such as Niemann-Pick disease type C. The coagulopathy associated with metabolic liver disease is often severe but may not be clinically apparent. Therefore, screenings for liver dysfunction, when there is suspicion of an underlying metabolic disorder, should always include prothrombin time, partial thromboplastin time, and fibrinogen.The presence of hepatosplenomegaly with slowly progressive psychomotor retardation suggests a diagnosis of a lysosomal storage disease (17) .
. In this study 31 out of 48 patients (65%) who were included in the study presented with dysmorphic facies in association with refractory epilepsy . Of these cases 13 Coma, organomegaly, seizures, developmental delay are significantly present in association with inborn errors of metabolism in many centre studies .Although each individual disease is rare but the whole sum of these metabolic disorders are not rare. The rarity of these disorders, different modes of presentation, atypical forms should raise the necessity for screening for these disorders to early pick up these cases to offer family counselling, early treatment and possibly early detection of these disorders in their siblings.. In this study showed no significant association between clinical data and urine metabolic screening test in the studied children due to study limitation. STUDY LIMITATION: 1-Relatively small sample size 2-It was a single-center study (ZagazigUniversity).3-Diagnosis of metabolic diseases requires more specific diagnostic tests. Conclusion IEMs are a rare cause of epilepsy but seizures and epilepsy are common in IEM, where the central nervous system carries the principal burden of disease. Many of these disorders are amenable to specific treatments and hence timely and appropriate diagnosis is essential to prevent irreversible brain damage. This requires knowledge about the clinical presentation, standardized vitamin trials, and availability of biochemical tests for diagnosis. IEMs that remain undiagnosed by clinical and biochemical testing, next-generation sequencing with gene panels, and whole exome sequencing may increase the diagnostic yield Compared with the positive rate of the urine metabolic screening tests in high risk infants suggest probability of the presence of a metabolic disease, which will need further specific investigations to determine the possible treatable cases. This is of fundamental importance for directing the awareness of
